Langerhans Cell Histiocytosis or Acute Cellular Rejection?
Pediatric Transplantation · 2024
DOI: 10.1111/petr.14884 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, 2024. Verfasst von Andreas Entenmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria. Hauptthemen laut MEDLINE: Antigens, CD1, Graft Rejection, Histiocytosis, Langerhans-Cell, Lectins, C-Type. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Langerhans cell histiocytosis (LCH) is a rare malignant disorder of epidermal antigen presenting cells. It is characterized by infiltration of various tissues with dendritic cells (Langerhans cells, LC) that express CD1a or CD207 (langerin), often leading to organ dysfunction. A patient with LCH required liver transplantation (LT) for LCH‐associated biliary‐tract disease. Cholangiopathy developed after LT. The question arose: In this patient, did LC in damaged liver‐allograft biliary epithelium signify acute cellular rejection (ACR) or recurrent LCH?
Methods
We evaluated immunohistochemical identification of LC (CD1a, CD207) in the proposita and in 14 ACR patient samples as distinguishing between ACR and recurrent LCH.
Results
Among 15 patient samples, 3 (20%) marked with neither antibody. Among the remaining 12 samples (80%), 4 (26.7%)—including that from the proposita—had cells marking for both antigens within bile‐duct epithelium as well as in surrounding portal‐tract connective tissue, 2 (13.3%) had cells marking for both antigens in one region or the other, but not in both, and 6 (40%) had cells marking for only one antigen in one region or the other.
Conclusions
Immunostaining for CD1a and CD207/langerin in the setting of ACR without suspicion of LCH identifies LC in damaged bile ducts. This biomarker pairing proved not to be LCH‐specific. Our findings indicate that the presence of these cells alone is insufficient to identify recurrent LCH in the allograft liver.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria.
- Department of Paediatrics and Adolescent Medicine, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.
- Department of Paediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
- Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.
- Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
ORCID-Profile: A S Knisely, Kristijan Skok
Zitieren
APA
Entenmann, A., Kogler, H., Huber, W. D., Kölz, M., Knisely, A. S., & Skok, K. (2024). Langerhans Cell Histiocytosis or Acute Cellular Rejection?. Pediatric Transplantation. https://doi.org/10.1111/petr.14884
Vancouver
Entenmann A, Kogler H, Huber WD, Kölz M, Knisely AS, Skok K. Langerhans Cell Histiocytosis or Acute Cellular Rejection?. Pediatric Transplantation. 2024. doi:10.1111/petr.14884
BibTeX
@article{Entenmann2024,
author = {Entenmann, Andreas and Kogler, Hubert and Huber, Wolf-Dietrich and Kölz, Marita and Knisely, A S and Skok, Kristijan},
title = {Langerhans Cell Histiocytosis or Acute Cellular Rejection?},
journal = {Pediatric Transplantation},
year = {2024},
doi = {10.1111/petr.14884}
}
EUVIMED